Table 4.
The characteristics of the 61 trials in ED registered on ClinicalTrial.gov.
| Characteristics | Number | Percentage (%) | |
|---|---|---|---|
| Study type | |||
| Interventional | 37 | 60.66 | |
| Observational | 24 | 39.34 | |
| Start year | |||
| 2004–2010 | 8 | 13.11 | |
| 2011–2016 | 19 | 31.15 | |
| 2017–2021 | 34 | 55.73 | |
| Enrollment | |||
| 0–100 | 14 | 22.95 | |
| 100–500 | 20 | 32.79 | |
| >500 | 27 | 44.26 | |
| Gender | |||
| Female only | 1 | 1.64 | |
| Both | 60 | 98.36 | |
| Participant age (year) | |||
| <18 | 6 | 9.84 | |
| ≥18 | 39 | 63.93 | |
| Both | 16 | 26.23 | |
| Status | |||
| Not recruiting | 9 | 14.75 | |
| Recruiting | 10 | 16.39 | |
| Completed | 30 | 49.18 | |
| Terminated/withdrawn | 6 | 9.84 | |
| Unknown | 6 | 9.84 | |
| Study results | |||
| Has results | 3 | 4.92 | |
| No results available | 58 | 95.08 | |
| Sponsor | |||
| University | 28 | 45.90 | |
| Hospital | 25 | 40.98 | |
| Industry/company | 4 | 6.56 | |
| Other | 4 | 6.56 | |
| Funding source | |||
| Industry | 4 | 6.56 | |
| Other | 57 | 93.44 | |
| Location | |||
| America | 28 | 45.90 | |
| Europe | 26 | 42.62 | |
| Asia | 1 | 1.64 | |
| Unknown | 6 | 9.84 | |